Main Session
Sep
29
SS 19 - Palliative Care 1: Palliative radiotherapy from SABR to EBRT: Improving QOL, prognostication, and toxicities
211 - Treatment with Stereotactic Ablative Radiotherapy for up to Five Oligometastases in Patients with Cancer: Long-Term Outcomes of the Nonrandomized Phase 2 SABR-5 Clinical Trial
Presenter(s)
Curtis Leclerc, MS - University of British Columbia, Vancouver, BC